EP0784974A1 — Solid dispersion or solid dispersion preparation of xanthine derivatives
Assigned to Kyowa Kirin Co Ltd · Expires 1997-07-23 · 29y expired
What this patent protects
A solid dispersion or solid dispersion preparation, each containing a xanthine derivative represented by general formula (I) or a pharmacologically acceptable salt thereof and a high-molecular-weight compound, wherein R 1 and R 2 may be the same or different and each represents…
USPTO Abstract
A solid dispersion or solid dispersion preparation, each containing a xanthine derivative represented by general formula (I) or a pharmacologically acceptable salt thereof and a high-molecular-weight compound, wherein R 1 and R 2 may be the same or different and each represents (un)substituted lower alkyl; and Q represents hxdrogen or hxdroxy.
Drugs covered by this patent
- Sporanox (itraconazole) · Sebela Ireland Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.